BACKGROUND: Surfactant protein (SP) D has been proposed to be protective in allergic airway responses. OBJECTIVE: We aimed to determine the effect of SP-D deficiency on murine and human airway allergy. METHODS: Immunologic responses of SP-D gene-deficient mice (Sftpd-/-) at baseline and after 4 intranasal Aspergillus fumigatus exposures were assessed. In addition, the significance of a single nucleotide polymorphism (Met(11)Thr) in the human SP-D gene (known to decrease SP-D function) was investigated. RESULTS: Macrophage and neutrophil bronchoalveolar lavage fluid levels and large airway mucus production were increased in naive Sftpd-/- mice in association with increased lung CCL17 levels and CD4+ T cell numbers. T(H)2-associated antibody levels (IgG1 and IgE) were significantly lower in 4- to 5-week-old Sftpd-/- mice (P < .05). Accordingly, naive Sftpd-/- splenocytes released significantly less IL-4 and IL-13 on anti-CD3/CD28 stimulation (P < .01). After intranasal allergen exposures, a modest decrease in bronchoalveolar lavage fluid eosinophilia and IL-13 levels was observed in Sftpd-/- mice compared with values seen in wild-type mice in association with decreased airway resistance (P < .01). A single nucleotide polymorphism in the SFTPD gene, affecting SP-D levels and pathogen binding, was associated with decreased atopy in black subjects and potentially lower asthma susceptibility in white subjects. CONCLUSION: Sftpd-/- mice have an impaired systemic T(H)2 response at baseline and reduced inflammation and airway responses after allergen exposure. Translational studies revealed that a polymorphism in the SFTPD gene was associated with lower atopy and possibly asthma susceptibility. Taken together, these results support the hypothesis that SP-D-dependent innate immunity influences atopy and asthma.
BACKGROUND:Surfactant protein (SP) D has been proposed to be protective in allergic airway responses. OBJECTIVE: We aimed to determine the effect of SP-D deficiency on murine and human airway allergy. METHODS: Immunologic responses of SP-D gene-deficient mice (Sftpd-/-) at baseline and after 4 intranasal Aspergillus fumigatus exposures were assessed. In addition, the significance of a single nucleotide polymorphism (Met(11)Thr) in the humanSP-D gene (known to decrease SP-D function) was investigated. RESULTS: Macrophage and neutrophil bronchoalveolar lavage fluid levels and large airway mucus production were increased in naive Sftpd-/- mice in association with increased lung CCL17 levels and CD4+ T cell numbers. T(H)2-associated antibody levels (IgG1 and IgE) were significantly lower in 4- to 5-week-old Sftpd-/- mice (P < .05). Accordingly, naive Sftpd-/- splenocytes released significantly less IL-4 and IL-13 on anti-CD3/CD28 stimulation (P < .01). After intranasal allergen exposures, a modest decrease in bronchoalveolar lavage fluid eosinophilia and IL-13 levels was observed in Sftpd-/- mice compared with values seen in wild-type mice in association with decreased airway resistance (P < .01). A single nucleotide polymorphism in the SFTPD gene, affecting SP-D levels and pathogen binding, was associated with decreased atopy in black subjects and potentially lower asthma susceptibility in white subjects. CONCLUSION:Sftpd-/- mice have an impaired systemic T(H)2 response at baseline and reduced inflammation and airway responses after allergen exposure. Translational studies revealed that a polymorphism in the SFTPD gene was associated with lower atopy and possibly asthma susceptibility. Taken together, these results support the hypothesis that SP-D-dependent innate immunity influences atopy and asthma.
Authors: Paul J Borron; Elahe A Mostaghel; Carolyn Doyle; Eric S Walsh; Michael G McHeyzer-Williams; Jo Rae Wright Journal: J Immunol Date: 2002-11-15 Impact factor: 5.422
Authors: Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee Journal: Science Date: 2006-12-22 Impact factor: 47.728
Authors: Deepika Jain; Elena Atochina-Vasserman; Helchem Kadire; Yaniv Tomer; Adam Inch; Pamela Scott; Rashmin C Savani; Andrew J Gow; Michael F Beers Journal: Am J Physiol Lung Cell Mol Physiol Date: 2006-12-08 Impact factor: 5.464
Authors: T Madan; U Kishore; A Shah; P Eggleton; P Strong; J Y Wang; S S Aggrawal; P U Sarma; K B Reid Journal: Clin Exp Immunol Date: 1997-11 Impact factor: 4.330
Authors: T R Korfhagen; V Sheftelyevich; M S Burhans; M D Bruno; G F Ross; S E Wert; M T Stahlman; A H Jobe; M Ikegami; J A Whitsett; J H Fisher Journal: J Biol Chem Date: 1998-10-23 Impact factor: 5.157
Authors: Elena N Atochina-Vasserman; Carla Winkler; Helen Abramova; Frank Schaumann; Norbert Krug; Andrew J Gow; Michael F Beers; Jens M Hohlfeld Journal: Am J Respir Crit Care Med Date: 2010-12-03 Impact factor: 21.405
Authors: Stephanie M Holmer; Kathy S Evans; Yohannes G Asfaw; Divey Saini; Wiley A Schell; Julie G Ledford; Richard Frothingham; Jo Rae Wright; Gregory D Sempowski; John R Perfect Journal: Infect Immun Date: 2013-11-25 Impact factor: 3.441